ArticleOncoTargets and therapy2020

Bruton's Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)-Suppressed Migration and Invasion of Prostate Cancer.

Zhen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.